MedTrace Logo

Dexmedetomidine vs Dexamethasone as Adjuvant to Bupivacaine in Bilevel Erector Spinae Plane Block in Breast Surgeries

NCT05591417 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2024-10-29

No results posted yet for this study

Summary

High percent of patients experience chronic pain following breast cancer surgeries thus proper perioperative pain control is crucial to lessen the incidence of such pain. Several techniques are adopted to control perioperative pain, these techniques include drugs as opioids and adjuvants as well as regional blocks. Erector spinae plane block is a regional technique that is used efficiently to control perioperative pain during and following breast cancer surgeries.

Conditions

  • Analgesia

Interventions

PROCEDURE

Bilevel Erector spinae plane block

Patients will receive bilevel erector spinae plane block with bupivacaine

PROCEDURE

Bilateral Erector spinae plane block with dexamethasone

Patients will receive bilevel erector spinae plane block with bupivacaine and dexamethasone

PROCEDURE

Bilateral Erector spinae plane block with dexmedetomidine

Patients will receive bilevel erector spinae plane block with bupivacaine and dexmedetomidine

DRUG

Intravenous morphine

Intravenous morphine 0.1 mg/kg

Sponsors & Collaborators

  • National Cancer Institute, Egypt

    lead OTHER

Principal Investigators

  • Walaa Y Elsabeeny, MD · Assistant Professor of Anesthesia and Pain Management, National Cancer Institute, Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-27
Primary Completion
2024-09-25
Completion
2024-09-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05591417 on ClinicalTrials.gov